Muridda conducts Phase I and Phase II clinical trials. Our clinical R&D team participates in the design of clinical trial protocols for new drugs during the preclinical animal study stage, enabling simpler, more efficient and comprehensive management of complex clinical trials. We help clients bring products to market as early as possible to meet public medical needs. Through our strict quality control system and the extensive experience of our professional team, we support innovative and breakthrough pharmaceutical products in launching quickly to benefit patients.
- Early Clinical Services:
- Clinical Operations
- Clinical Data Management and Statistical Analysis
- Medical Affairs
- Regulatory Affairs
- Quality System Management and Consultancy
- Single-region Phase II Clinical Trials
- Bioanalysis
- Drug Distribution Studies
- Immunotoxicity and Immunogenicity of Biologics
- Volunteer Subjects